| SHILPA MEDICARE  Back to Balance Sheet | 
SHILPA MEDICARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹260 Cr | ₹589 Cr | ₹345 Cr | ₹453 Cr | ₹561 Cr | 
What is the latest Total Non-Current Liabilities ratio of SHILPA MEDICARE ?
| Year | Total Non-Current Liabilities | 
|---|---|
| Mar2025 | ₹260 Cr | 
| Mar2024 | ₹589 Cr | 
| Mar2023 | ₹345 Cr | 
| Mar2022 | ₹453 Cr | 
| Mar2021 | ₹561 Cr | 
How is Total Non-Current Liabilities of SHILPA MEDICARE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹260 Cr | -55.92 | |
| Mar2024 | ₹589 Cr | 70.79 | |
| Mar2023 | ₹345 Cr | -23.78 | |
| Mar2022 | ₹453 Cr | -19.34 | |
| Mar2021 | ₹561 Cr | - | |
Compare Total Non-Current Liabilities of peers of SHILPA MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHILPA MEDICARE | ₹7,060.2 Cr | -0.6% | -5.9% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,751.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,634.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹124,437.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,871.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,333.0 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
SHILPA MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| SHILPA MEDICARE | -0.6% | -5.9% | -8.7% | 
| SENSEX | -0.2% | 5% | 5.4% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    